» Articles » PMID: 26291312

A Novel LncRNA, LUADT1, Promotes Lung Adenocarcinoma Proliferation Via the Epigenetic Suppression of P27

Overview
Journal Cell Death Dis
Date 2015 Aug 21
PMID 26291312
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) are known to regulate the development and progression of various cancers. However, few lncRNAs have been well characterized in lung adenocarcinoma (LUAD). Here, we identified the expression profile of lncRNAs and protein-coding genes via microarrays analysis of paired LUAD tissues and adjacent non-tumor tissues from five female non-smokes with LUAD. A total of 498 lncRNAs and 1691 protein-coding genes were differentially expressed between LUAD tissues and paired adjacent normal tissues. A novel lncRNA, LUAD transcript 1 (LUADT1), which is highly expressed in LUAD and correlates with T stage, was characterized. Both in vitro and in vivo data showed that LUADT1 knockdown significantly inhibited proliferation of LUAD cells and induced cell cycle arrest at the G0-G1 phase. Further analysis indicated that LUADT1 may regulate cell cycle progression by epigenetically inhibiting the expression of p27. RNA immunoprecipitation and chromatin immunoprecipitation assays confirmed that LUADT1 binds to SUZ12, a core component of polycomb repressive complex 2, and mediates the trimethylation of H3K27 at the promoter region of p27. The negative correlation between LUADT1 and p27 expression was confirmed in LUAD tissue samples. These data suggested that a set of lncRNAs and protein-coding genes were differentially expressed in LUAD. LUADT1 is an oncogenic lncRNA that regulates LUAD progression, suggesting that dysregulated lncRNAs may serve as key regulatory factors in LUAD progression.

Citing Articles

Diagnostics and Therapy for Malignant Tumors.

Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T Biomedicines. 2025; 12(12.

PMID: 39767566 PMC: 11726849. DOI: 10.3390/biomedicines12122659.


The expression and role of SUZ12 in lung adenocarcinoma.

Hu X, Hu C, Zhong P Cancer Med. 2024; 13(19):e70190.

PMID: 39400513 PMC: 11471883. DOI: 10.1002/cam4.70190.


Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.

Lv X, Yang L, Xie Y, Momeni M Front Cell Dev Biol. 2024; 12:1397788.

PMID: 38859962 PMC: 11163066. DOI: 10.3389/fcell.2024.1397788.


Prostate cancer biomarkers: from early diagnosis to precision treatment.

Dahiya V, Hans S, Kumari R, Bagchi G Clin Transl Oncol. 2024; 26(10):2444-2456.

PMID: 38744755 DOI: 10.1007/s12094-024-03508-2.


Emerging role of exosome-derived non-coding RNAs in tumor-associated angiogenesis of tumor microenvironment.

Duan S, Fu W, Jiang Y, Peng L, Ousmane D, Zhang Z Front Mol Biosci. 2023; 10:1220193.

PMID: 37602326 PMC: 10436220. DOI: 10.3389/fmolb.2023.1220193.


References
1.
Pujana M, Han J, Starita L, Stevens K, Tewari M, Ahn J . Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet. 2007; 39(11):1338-49. DOI: 10.1038/ng.2007.2. View

2.
Shen J, Yin J, Li X, Liu Z, Wang Y, Chen J . The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PLoS One. 2014; 9(4):e96008. PMC: 4005749. DOI: 10.1371/journal.pone.0096008. View

3.
Brockdorff N . Noncoding RNA and Polycomb recruitment. RNA. 2013; 19(4):429-42. PMC: 3677253. DOI: 10.1261/rna.037598.112. View

4.
Wang L, Park H, Dasari S, Wang S, Kocher J, Li W . CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013; 41(6):e74. PMC: 3616698. DOI: 10.1093/nar/gkt006. View

5.
Singhal S, Vachani A, Antin-Ozerkis D, Kaiser L, Albelda S . Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res. 2005; 11(11):3974-86. DOI: 10.1158/1078-0432.CCR-04-2661. View